Denali Therapeutics Inc (DNLI) support and resistance · $2.11B cap
Denali Therapeutics Inc (DNLI) is a biotechnology company listed on US.
This page maps Denali Therapeutics Inc (DNLI) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported DNLI revenue for 2024-12-31 was $0. Net income was -$422.8M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. DNLI currently screens at market cap $2.11B.
DNLI currently screens at market cap $2.11B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new DNLI 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the DNLI quote page for the session range and the stock page for the full model.
Not investment advice.